Wellgistics Health, Inc. (WGRX)
| Market Cap | 10.83M -95.4% |
| Revenue (ttm) | 14.03M -51.6% |
| Net Income | -76.59M |
| EPS | -0.91 |
| Shares Out | 125.67M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,161,439 |
| Open | 0.0981 |
| Previous Close | 0.1070 |
| Day's Range | 0.0852 - 0.1017 |
| 52-Week Range | 0.0702 - 2.6600 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 19, 2026 |
About WGRX
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub... [Read more]
Financial Performance
In 2025, Wellgistics Health's revenue was $23.34 million, an increase of 28.73% compared to the previous year's $18.13 million. Losses were -$101.27 million, 1377.1% more than in 2024.
Financial StatementsNews
CORRECTION FROM SOURCE: Wellgistics Health Releases Letter to Our Shareholders
This Press Release updates the information from the previous release. Why Vertical Integration and Blockchain Will Define the Next Era of Healthcare TAMPA, FL / ACCESS Newswire / May 21, 2026 / Wellgi...
Wellgistics sees vertical integration as ‘only path’ to efficiency in healthcare
In a letter to shareholders, the company said, in part, “Yesterday we announced a series of transactions that, taken together, mark the most consequential strategic moment in Wellgistics Health’s (WGR...
Wellgistics Health Releases Letter to Our Shareholders
Why Vertical Integration and Blockchain Will Define the Next Era of Healthcare PHILADELPHIA, PA / ACCESS Newswire / May 21, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company"), a provider of da...
Wellgistics Health implements 1-for-50 reverse stock split
Wellgistics Health (WGRX) approved a 1-for-50 reverse stock split of the company’s common stock, par value $0.00001 per share. The reverse split was approved by a majority of the stockholders…
Wellgistics Health Announces Reverse Stock Split
TAMPA, FL / ACCESS Newswire / May 20, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a health information technology leader, integrating proprietary pharmacy dispensin...
Datavault, Wellgistics to form DelivMeds AI via PharmacyChain license expansion
Datavault AI (DVLT) entered into a fully binding term sheet with Wellgistics Health (WGRX), integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx into it...
Wellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain™ License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo Health
PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset (‘RWA') token...
Wellgistics Health Reports First Quarter 2026 Financials and Provides Business Update
Wellgistics Pharmacy monthly revenue increased from approximately $0.1 million in November 2025 to approximately $0.6 million in April 2026, based on preliminary unaudited results Q1-26 focus on optim...
Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026
TAMPA, FL / ACCESS Newswire / May 15, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today ann...
Wellgistics Health announces pilot MSO collaboration with Kare PharmTech
Wellgistics Health (WGRX) announced a pilot collaboration with Kare PharmTech and Kare Clinicals integrating its MSO infrastructure to support chronic care management and remote patient monitoring ser...
Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Highlights: According to third-party industry reports, the U.S. RPM market is currently $14 Billion alone and expected to reach approximately $29 Billion by 2030, representing a 12.6% CAGR, as healthc...
Wellgistics Health files $200M mixed securities shelf
17:25 EDT Wellgistics Health (WGRX) files $200M mixed securities shelf
Wellgistics Health, Kare PharmTech execute joint venture
Wellgistics Health (WGRX) announced the execution of a definitive joint venture agreement with Kare PharmTech’s wholly owned subsidiary, Kare Rx Hub, an artificial intelligence-driven digital hub supp...
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Joint venture executed combining Wellgistics Hub and KareRx Hub technology and operations Integrated platform accelerates pharmaceutical access, fulfillment, and commercialization Combined ecosystem p...
Wellgistics enters LOI to evaluate potential acquisition of Neuritek
Wellgistics Health (WGRX) announced that it has entered into a non-exclusive, non-binding Letter of Intent, LOI, to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused re...
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
TAMPA, FL / ACCESS Newswire / March 23, 2026 / Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of I...
Wellgistics Health converts $2M in deferred compensation equity at 20c per share
Wellgistics Health (WGRX), announced that its President and Interim Chief Executive Officer, Prashant Patel, together with an additional participant from the Company’s Board of Directors, entered into...
Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share
TAMPA, FL / ACCESS Newswire / March 19, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization ...
Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction
TAMPA, FL / ACCESS Newswire / March 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization ...
Wellgistics Health announces insurance EBV capabilities for PharmacyChain
Wellgistics Health (WGRX) has secured contractual rights to preferred pricing for medical insurance eligibility and benefits verification that enables PharmacyChain for providers, partners and pharmac...
Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities
Medical insurance eligibility and benefits verification (EBV) is a core health technology capability necessary for PharmacyChain™ to gain market adoption EBV services offering enabled with preferred p...
Wellgistics Health launches Forzet for muscle loss linked with weight loss drugs
Wellgistics Health (WGRX) announced the launch of medical food Forzet for the dietary management of muscle loss associated with weight loss therapies. Forzet is being launched initially to physicians ...
Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM)
GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301 Proprietary Forzet formulation provides pharmacists, physicians and patients with unique solution for GLP-1 drugs' primary sid...
Wellgistics selects five blockchain platforms for PharmacyChain development
Wellgistics Health (WGRX) has completed its evaluation process to select the most suitable blockchain platforms on which to build smart contracts-enabled pharmaceutical drug tracking system PharmacyCh...
Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate
Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum /Besu and Corda (R3) selected as most suitable blockchain platforms to build PharmacyChain™ U.S. prescription drugs market project to grow from $6...